Functional screening identifies CRLF2 in precursor B-cell acute lymphoblastic leukemia
暂无分享,去创建一个
P. D. Dal Cin | J. Aster | J. Bradner | R. Foà | K. Mani | S. Chiaretti | J. Ritz | C. Mitsiades | S. Rodig | J. Griffin | D. DeAngelo | R. Stone | M. Wadleigh | D. Weinstock | M. Sattler | Jennifer R. Brown | D. Frank | N. West | J. Kutok | M. Bar‐Natan | A. Yoda | Yun Xiao | A. Piciocchi | Y. Yoda | K. Anderson | P. Dal Cin
[1] J. Downing,et al. Rearrangement of CRLF2 in B-progenitor– and Down syndrome–associated acute lymphoblastic leukemia , 2009, Nature Genetics.
[2] J. Rowe,et al. Hematopoietic stem cell transplantation for adults with acute lymphoblastic leukemia , 2009, Current opinion in hematology.
[3] Takashi Akasaka,et al. Deregulated expression of cytokine receptor gene, CRLF2, is involved in lymphoid transformation in B-cell precursor acute lymphoblastic leukemia. , 2009, Blood.
[4] F. Alt,et al. Mechanisms promoting translocations in editing and switching peripheral B cells , 2009, Nature.
[5] M. Loh,et al. JAK mutations in high-risk childhood acute lymphoblastic leukemia , 2009, Proceedings of the National Academy of Sciences.
[6] O. Ottmann,et al. First-line treatment of Philadelphia chromosome-positive acute lymphoblastic leukaemia in adults , 2009, Current opinion in oncology.
[7] N. Heerema,et al. Prevalence and clinical correlates of JAK2 mutations in Down syndrome acute lymphoblastic leukaemia , 2009, British journal of haematology.
[8] O. Bernard,et al. A novel translocation, t(14;19)(q32;p13), involving IGH@ and the cytokine receptor for erythropoietin , 2009, Leukemia.
[9] Christopher B. Miller,et al. Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia. , 2009, The New England journal of medicine.
[10] K. Anderson,et al. Specific JAK2 mutation (JAK2R683) and multiple gene deletions in Down syndrome acute lymphoblastic leukemia. , 2009, Blood.
[11] James R. Downing,et al. Genomic Analysis of the Clonal Origins of Relapsed Acute Lymphoblastic Leukemia , 2008, Science.
[12] A. Baruchel,et al. Activating mutations in human acute megakaryoblastic leukemia. , 2008, Blood.
[13] C. Mullighan. JAK2—a new player in acute lymphoblastic leukaemia , 2008, The Lancet.
[14] G. Wainreb,et al. Mutations of JAK2 in acute lymphoblastic leukaemias associated with Down's syndrome , 2008, The Lancet.
[15] D. Gary Gilliland,et al. Activating mutations in ALK provide a therapeutic target in neuroblastoma , 2008, Nature.
[16] K. Döhner,et al. Prognostic implications of gene mutations in acute myeloid leukemia with normal cytogenetics. , 2008, Seminars in oncology.
[17] Christopher B. Miller,et al. BCR–ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros , 2008, Nature.
[18] P. Grigsby,et al. Notch-Deficient Skin Induces a Lethal Systemic B-Lymphoproliferative Disorder by Secreting TSLP, a Sentinel for Epidermal Integrity , 2008, PLoS biology.
[19] D. Teachey,et al. Thymic stromal-derived lymphopoietin induces proliferation of pre-B leukemia and antagonizes mTOR inhibitors, suggesting a role for interleukin-7Ralpha signaling. , 2007, Cancer research.
[20] Takashi Akasaka,et al. Five members of the CEBP transcription factor family are targeted by recurrent IGH translocations in B-cell precursor acute lymphoblastic leukemia (BCP-ALL). , 2007, Blood.
[21] Christopher B. Miller,et al. Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia , 2007, Nature.
[22] Dejan Juric,et al. Differential gene expression patterns and interaction networks in BCR-ABL-positive and -negative adult acute lymphoblastic leukemias. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[23] W. Vainchenker,et al. Novel activating JAK2 mutation in a patient with Down syndrome and B-cell precursor acute lymphoblastic leukemia. , 2007, Blood.
[24] M. Meyerson,et al. Non-small-cell lung cancer and Ba/F3 transformed cells harboring the ERBB2 G776insV_G/C mutation are sensitive to the dual-specific epidermal growth factor receptor and ERBB2 inhibitor HKI-272. , 2006, Cancer research.
[25] K. Kurokawa,et al. Self-association of the transmembrane domain of RET underlies oncogenic activation by MEN2A mutations , 2006, Oncogene.
[26] H. Lodish,et al. Active Conformation of the Erythropoietin Receptor , 2006, Journal of Biological Chemistry.
[27] H. Lodish,et al. Expression of a homodimeric type I cytokine receptor is required for JAK2V617F-mediated transformation. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[28] Robert Gentleman,et al. Gene Expression Profiles of B-lineage Adult Acute Lymphocytic Leukemia Reveal Genetic Patterns that Identify Lineage Derivation and Distinct Mechanisms of Transformation , 2005, Clinical Cancer Research.
[29] M. Meyerson,et al. Epidermal growth factor-independent transformation of Ba/F3 cells with cancer-derived epidermal growth factor receptor mutants induces gefitinib-sensitive cell cycle progression. , 2005, Cancer research.
[30] J. Harbott,et al. Gene expression patterns associated with recurrent chromosomal translocations in acute lymphoblastic leukemia. , 2004, Blood.
[31] J. Downing,et al. Classification of pediatric acute lymphoblastic leukemia by gene expression profiling. , 2003, Blood.
[32] Aniko Szabo,et al. Identification of gene expression profiles that segregate patients with childhood leukemia. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.
[33] R. Fishel,et al. Fusion Tyrosine Kinases Induce Drug Resistance by Stimulation of Homology-Dependent Recombination Repair, Prolongation of G2/M Phase, and Protection from Apoptosis , 2002, Molecular and Cellular Biology.
[34] Riccardo Dalla-Favera,et al. Mechanisms of chromosomal translocations in B cell lymphomas , 2001, Oncogene.
[35] R. de Waal Malefyt,et al. Human Thymic Stromal Lymphopoietin Preferentially Stimulates Myeloid Cells1 , 2001, The Journal of Immunology.
[36] Heinz Baumann,et al. Cloning of a receptor subunit required for signaling by thymic stromal lymphopoietin , 2000, Nature Immunology.
[37] Thomas S. Lin,et al. STAT signaling in the pathogenesis and treatment of leukemias , 2000, Oncogene.
[38] R. Perlmutter,et al. Thymic stromal lymphopoietin: a cytokine that promotes the development of IgM+ B cells in vitro and signals via a novel mechanism. , 1999, Journal of immunology.
[39] Z. Estrov,et al. Clinical significance of cytogenetic abnormalities in adult acute lymphoblastic leukemia. , 1998, Blood.
[40] Yong‐jun Liu. TSLP in epithelial cell and dendritic cell cross talk. , 2009, Advances in immunology.
[41] Takashi Akasaka,et al. t(6;14)(p22;q32): a new recurrent IGH@ translocation involving ID4 in B-cell precursor acute lymphoblastic leukemia (BCP-ALL). , 2008, Blood.
[42] Minoru Kanehisa,et al. The KEGG database. , 2002, Novartis Foundation symposium.